Lymphocyte Subset Alteration and Monocyte CD4 Expression Reduction in Patients with Severe COVID-19
Viral Immunology · 2021-06-01 · 34 (5) · 342-351
DOI: 10.1089/vim.2020.0166 ↗At a glance
Journal article in Viral Immunology, published on 2021-06-01. Written by Sumeyye Kazancioglu and 7 co-authors. Institution: Department of Infectious Diseases and Clinical Microbiology, and Ministry of Health Ankara City Hospital, Ankara, Turkey. Major MEDLINE topics: Immunity, Cellular, Severity of Illness Index. Cited 38 times so far (Crossref); 30 references.
Abstract (original language)
The spectrum of coronavirus disease 2019 (COVID-19) severity, related to cellular immune functions, has not been fully clarified yet. Therefore, this study aimed to investigate the alteration of peripheral blood cells in patients with COVID-19. The flow cytometric characterization of immune cell subset was performed on 69 COVID-19 patients and 21 healthy controls. These data were evaluated based on the disease severity. A total of 69 patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were classified as asymptomatic infection (n = 14), nonsevere (n = 39), and severe (n = 16) groups. Decreased lymphocytes and increased CD14 + 4- monocytes are found in patients with severe COVID-19. Decreased CD4 expression level was observed in the monocytes of patients with severe COVID-19. The total lymphocytes, B and T lymphocytes, CD4+ cells and CD8+ cells, and natural killer (NK) and natural killer T (NKT) cells were found to be decreased in patients with severe COVID-19. The CD4+/CD8+ ratio was not significantly different between patients with COVID-19 and healthy controls. The percentage of activated T cells (CD3+HLA-DR+) and B cells (CD19+CD38+) was lower in patients with severe COVID-19. Age and CD4- monocytes were independent predictors of disease severity. The SARS-CoV-2 infection may affect lymphocyte subsets, resulting in decreased T and B cells, monocytes, and NK and NKT cells. Decreased CD4 expression level by monocytes was significantly correlated with disease severity. Further studies on the host immune response to SARS-CoV-2 infection are necessary to predict the disease severity and protect against the virus.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Infectious Diseases and Clinical Microbiology, and Ministry of Health Ankara City Hospital, Ankara, Turkey.
- Medical Biochemistry Laboratory, Ministry of Health Ankara City Hospital, Ankara, Turkey.
- Faculty of Medicine, Medical Biochemistry Department, Ankara Yıldırım Beyazıt University, Ankara, Turkey.
- Department of Infectious Diseases and Clinical Microbiology, Ankara City Hospital, Health Science University Turkey, Ankara, Turkey.
Cite
APA
Kazancioglu, S., Yilmaz, F. M., Bastug, A., Sakallı, A., Ozbay, B. O., Buyuktarakci, C., Bodur, H., & Yilmaz, G. (2021). Lymphocyte Subset Alteration and Monocyte CD4 Expression Reduction in Patients with Severe COVID-19. Viral Immunology, 34(5), 342-351. https://doi.org/10.1089/vim.2020.0166
Vancouver
Kazancioglu S, Yilmaz FM, Bastug A, Sakallı A, Ozbay BO, Buyuktarakci C, et al. Lymphocyte Subset Alteration and Monocyte CD4 Expression Reduction in Patients with Severe COVID-19. Viral Immunology. 2021;34(5):342-351. doi:10.1089/vim.2020.0166
BibTeX
@article{Kazancioglu2021,
author = {Kazancioglu, Sumeyye and Yilmaz, Fatma Meric and Bastug, Aliye and Sakallı, Arzu and Ozbay, Bahadır Orkun and Buyuktarakci, Cansu and Bodur, Hurrem and Yilmaz, Gulsen},
title = {Lymphocyte Subset Alteration and Monocyte CD4 Expression Reduction in Patients with Severe COVID-19},
journal = {Viral Immunology},
year = {2021},
volume = {34},
number = {5},
pages = {342--351},
doi = {10.1089/vim.2020.0166}
}
EUVIMED